NCT00101712View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia

PHASE3CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

DRUG

Vildagliptin Placebo

Trial Locations (2)

Unknown

Novartis Investigative Site, Investigative Site

Novartis Investigative Site, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY